Actively Recruiting
Phase 3 Study of Enpatoran for Treating Active Skin Symptoms of Lupus With or Without Systemic Disease
Led by EMD Serono Research & Development Institute, Inc. · Updated on 2026-07-17
202
Participants Needed
13
Research Sites
N/A
Total Duration
AI-Summary
What this Trial Is About
Researchers are studying enpatoran in adults with active skin symptoms of lupus erythematosus, with or without systemic involvement. This global, multicenter Phase 3 trial aims to assess the effectiveness and safety of enpatoran compared to a placebo over 24 weeks. Participants must have certain types of cutaneous lupus, including discoid, subacute, or acute forms, and may also have systemic lupus erythematosus SLE. The study is sponsored by EMD Serono Research & Development Institute, Inc.
CONDITIONS
Brief Title
A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)
Research Team
U
US Medical Information
C
Communication Center
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
